Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report

Sex discordance between cell-free DNA (cfDNA) testing and ultrasound examination is rare but can cause significant patient discomfort and uncertainty. Here, we present two clinical cases where a closer examination of raw sequencing data allowed us to anticipate possible discrepancies caused by the i...

Full description

Saved in:
Bibliographic Details
Main Authors: Nuria Balaguer, Emilia Mateu-Brull, Jose Antonio Martínez-Conejero, Ana Cervero, Roser Navarro, Jorge Jiménez-Almazán, Miguel Milán
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1502287/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593936830431232
author Nuria Balaguer
Emilia Mateu-Brull
Jose Antonio Martínez-Conejero
Ana Cervero
Roser Navarro
Jorge Jiménez-Almazán
Miguel Milán
author_facet Nuria Balaguer
Emilia Mateu-Brull
Jose Antonio Martínez-Conejero
Ana Cervero
Roser Navarro
Jorge Jiménez-Almazán
Miguel Milán
author_sort Nuria Balaguer
collection DOAJ
description Sex discordance between cell-free DNA (cfDNA) testing and ultrasound examination is rare but can cause significant patient discomfort and uncertainty. Here, we present two clinical cases where a closer examination of raw sequencing data allowed us to anticipate possible discrepancies caused by the insertion of Y-chromosome regions into the maternal genome. We used Illumina’s VeriSeq NIPT Solution v2 and a proprietary bioinformatics pipeline to analyze cfDNA in the maternal bloodstream. Paired-end sequencing data were aligned to the reference genome (hg19). Non-duplicated aligned reads were aggregated into 100-kb bins, adjusted for CG bias, and further aggregated into 5-Mb windows. Z-scores were calculated for autosomes, sex chromosomes, and 5-Mb bins. The two clinical cases were classified as low-risk male fetuses according to the primary statistics (case A: NCVx = 0.3; NCVy = 40.6; native fetal fraction (FFi) = 5.1%, and case B: NCVx = −0.3, NCVy = 40.7, FFi = 10.8%); however, the Y-chromosome-based FF (FFy) was significantly lower than the default FF estimate (FFy ≅ 2% in both cases). Plots of X and Y chromosome Z-scores for each 5-Mb bin, according to genomic position, identified bins with Z-scores significantly higher than those expected for any pregnancy with a male fetus. The genomic coordinates of these bins overlapped with the amelogenin (AMELY) and protein kinase Y-linked (PRKY) genes, respectively. Amplification of these regions in the DNA isolated from the white blood cells fraction confirmed the presence of Y-chromosome insertions in the maternal genome. This study highlights a new source of discrepancy in cfDNA testing due to maternal genomic variations. These findings suggest the need for improvements to current bioinformatics pipelines to identify and exclude possible maternal perturbations from the classification algorithms used for aneuploidy and sex calls.
format Article
id doaj-art-7afe9806dade42c39cecb91cc6b18142
institution Kabale University
issn 1664-8021
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-7afe9806dade42c39cecb91cc6b181422025-01-20T07:20:26ZengFrontiers Media S.A.Frontiers in Genetics1664-80212025-01-011510.3389/fgene.2024.15022871502287Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case reportNuria Balaguer0Emilia Mateu-Brull1Jose Antonio Martínez-Conejero2Ana Cervero3Roser Navarro4Jorge Jiménez-Almazán5Miguel Milán6Prenatal Diagnosis Department, Igenomix Spain Lab, Valencia, SpainPrenatal Diagnosis Department, Igenomix Spain Lab, Valencia, SpainPre-implantation Genetic Testing for Monogenic Diseases Department, Igenomix Spain Lab, Valencia, SpainPre-implantation Genetic Testing for Monogenic Diseases Department, Igenomix Spain Lab, Valencia, SpainBioinformatics Department, Igenomix Spain Lab, Valencia, SpainBioinformatics Department, Igenomix Spain Lab, Valencia, SpainPrenatal Diagnosis Department, Igenomix Spain Lab, Valencia, SpainSex discordance between cell-free DNA (cfDNA) testing and ultrasound examination is rare but can cause significant patient discomfort and uncertainty. Here, we present two clinical cases where a closer examination of raw sequencing data allowed us to anticipate possible discrepancies caused by the insertion of Y-chromosome regions into the maternal genome. We used Illumina’s VeriSeq NIPT Solution v2 and a proprietary bioinformatics pipeline to analyze cfDNA in the maternal bloodstream. Paired-end sequencing data were aligned to the reference genome (hg19). Non-duplicated aligned reads were aggregated into 100-kb bins, adjusted for CG bias, and further aggregated into 5-Mb windows. Z-scores were calculated for autosomes, sex chromosomes, and 5-Mb bins. The two clinical cases were classified as low-risk male fetuses according to the primary statistics (case A: NCVx = 0.3; NCVy = 40.6; native fetal fraction (FFi) = 5.1%, and case B: NCVx = −0.3, NCVy = 40.7, FFi = 10.8%); however, the Y-chromosome-based FF (FFy) was significantly lower than the default FF estimate (FFy ≅ 2% in both cases). Plots of X and Y chromosome Z-scores for each 5-Mb bin, according to genomic position, identified bins with Z-scores significantly higher than those expected for any pregnancy with a male fetus. The genomic coordinates of these bins overlapped with the amelogenin (AMELY) and protein kinase Y-linked (PRKY) genes, respectively. Amplification of these regions in the DNA isolated from the white blood cells fraction confirmed the presence of Y-chromosome insertions in the maternal genome. This study highlights a new source of discrepancy in cfDNA testing due to maternal genomic variations. These findings suggest the need for improvements to current bioinformatics pipelines to identify and exclude possible maternal perturbations from the classification algorithms used for aneuploidy and sex calls.https://www.frontiersin.org/articles/10.3389/fgene.2024.1502287/fullsex discordancey-chromosomematernal abnormalitiesnon-invasive prenatal testing (NIPT)cell-free (fetal) DNAcase-report
spellingShingle Nuria Balaguer
Emilia Mateu-Brull
Jose Antonio Martínez-Conejero
Ana Cervero
Roser Navarro
Jorge Jiménez-Almazán
Miguel Milán
Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report
Frontiers in Genetics
sex discordance
y-chromosome
maternal abnormalities
non-invasive prenatal testing (NIPT)
cell-free (fetal) DNA
case-report
title Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report
title_full Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report
title_fullStr Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report
title_full_unstemmed Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report
title_short Tell me y: anticipation of sex discrepancies in cell-free DNA testing due to maternal genetic abnormalities: a case report
title_sort tell me y anticipation of sex discrepancies in cell free dna testing due to maternal genetic abnormalities a case report
topic sex discordance
y-chromosome
maternal abnormalities
non-invasive prenatal testing (NIPT)
cell-free (fetal) DNA
case-report
url https://www.frontiersin.org/articles/10.3389/fgene.2024.1502287/full
work_keys_str_mv AT nuriabalaguer tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport
AT emiliamateubrull tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport
AT joseantoniomartinezconejero tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport
AT anacervero tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport
AT rosernavarro tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport
AT jorgejimenezalmazan tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport
AT miguelmilan tellmeyanticipationofsexdiscrepanciesincellfreednatestingduetomaternalgeneticabnormalitiesacasereport